15.21
Anika Therapeutics Inc (ANIK) 最新ニュース
Anika Therapeutics stock hits 52-week low at $15.34 - Investing.com
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2024 Earnings Call Transcript - Insider Monkey
Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
Anika Therapeutics Reports Steady Growth and Strategic Focus - TipRanks
Earnings call transcript: Anika Therapeutics Q4 2024 beats EPS forecast, stock dips - Investing.com India
Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Anika Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Anika: Q4 Earnings Snapshot -March 12, 2025 at 04:34 pm EDT - Marketscreener.com
ANIKA THERAPEUTICS Earnings Results: $ANIK Reports Quarterly Earnings - Nasdaq
Anika Therapeutics Q4 Swings to Adjusted Loss, Revenue Rises -- Shares Drop After Hours - Marketscreener.com
Anika Therapeutics, Inc. Reports 2024 Financial Results with 17% Growth in Commercial Channel Revenue and Key Strategic Advances - Nasdaq
Anika Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
Anika's Commercial Channel Soars 25% in Q4: Inside the Transformation Strategy - StockTitan
Anika Therapeutics Sells Parcus Medical to Medacta - TipRanks
Anika Therapeutics at CG 2025 Musculoskeletal Conference: Strategic Growth Unveiled - Investing.com Canada
ANIKA THERAPEUTICS Earnings Preview: Recent $ANIK Insider Trading, Hedge Fund Activity, and More - Nasdaq
(ANIK) Investment Report - Stock Traders Daily
Anika Therapeutics falls after its completes divestiture of Parcus Medical business - TradingView
Anika Completes Divestiture of Parcus Medical - citybiz
Anika Therapeutics Completes Divestiture of Parcus Medical to Medacta -March 07, 2025 at 06:38 am EST - Marketscreener.com
Anika Therapeutics (ANIK) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Anika Therapeutics Completes Sale of Parcus Medical to Medacta Group SA - Nasdaq
Can Anika's Strategic Exit from Parcus Medical Transform Its Growth Trajectory? - StockTitan
Knee Cartilage Repair Market Generated Opportunities, Future - openPR
Anika Therapeutics (ANIK) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Viscosupplementation Market Detailed In New Research Report 2025 | Anika Therapeutics Inc., Seikagaku Corporation - openPR
Is Anika Therapeutics, Inc. (ANIK) the Best Small Cap Pharma Stock to Buy Now? - Insider Monkey
Is Anika Therapeutics, Inc. (ANIK) the Best Small Cap Pharma Stocks to Buy Now? - Yahoo Finance
Investor Network: Anika Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025 - GlobeNewswire
When Will Anika Reveal Its 2024 Performance? Key Date for Joint Preservation Investors - StockTitan
Trading (ANIK) With Integrated Risk Controls - Stock Traders Daily
Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference - GlobeNewswire
Can Anika's CEO Reveal New Orthopedic Strategy at Upcoming Canaccord Conference? - StockTitan
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Comparing Lyra Therapeutics (NASDAQ:LYRA) & Anika Therapeutics (NASDAQ:ANIK) - Defense World
How to Take Advantage of moves in (ANIK) - Stock Traders Daily
SG Americas Securities LLC Reduces Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Global Hyaluronic Acid for Osteoarthritis Market Reached - openPR
Viscosupplementation Market Global Forecast Report and Company Analysis 2025-2033 Featuring Anika Therapeutics, Zimmer Biomet, Smith & Nephew, F.Hoffmann-La Roche, Sanofi, Chugai, Lifecore, LGResearchAndMarkets.com | FinancialContent Busi - Financial Content
Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 48%? - Yahoo Finance
BlackRock, Inc. Reduces Stake in Anika Therapeutics Inc - GuruFocus.com
JPMorgan Chase & Co. Sells 11,072 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Dimensional Fund Advisors LP Reduces Stake in Anika Therapeutics Inc - GuruFocus.com
Facial Aesthetics Market Generated Opportunities, Future - openPR
Orthopedic Digit Implants Market: Share, Revenue Insights, - openPR
Barclays PLC Purchases 13,054 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Viscosupplementation Market Generated Opportunities, Future - openPR
(ANIK) Proactive Strategies - Stock Traders Daily
Anika Therapeutics stock hits 52-week low at $15.8 By Investing.com - Investing.com Australia
Anika Therapeutics stock hits 52-week low at $15.8 - Investing.com India
Jane Street Group LLC Increases Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Geode Capital Management LLC - Defense World
大文字化:
|
ボリューム (24 時間):